The story of Viagra, and its creator copyright, presents a intriguing case study for investors. At first a blockbuster drug, yielding billions in sales , its intellectual property lapse created a deluge of generic competition , significantly impacting its market share . While certain businesses may seek to capitalize on related treatments , the pre